Brought to you by 
Senseonics announces $80mm debt financing
22 Jul 2019
Executive Summary
Senseonics Holdings Inc. (developing a continuous glucose monitoring system for diabetics) commenced an offering of $80mm aggregate principal amount of 5.25% convertible senior notes due 2025 to Solar Capital. The company will use some of the proceeds to fully repay its existing credit facility with Oxford Finance and Silicon Valley Bank. Senseonics concurrently netted $23.5mm via a follow-on offering.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Senseonics announces $80mm debt financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice